 Home > Biochemistry News > Biotechnology News > Reduce cough frequency by 34%, innovative P2X3 receptor antagonist Phase 2 clinical results are positive

Reduce cough frequency by 34%, innovative P2X3 receptor antagonist Phase 2 clinical results are positive

 Last Update: 2021-12-29
 Source: Internet
 Author: User

Tags

magnetic water treatment

positive tpo antibodies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 13, 2021, Bellus Health announced that a phase 2b clinical trial of the selective oral P2X3 receptor antagonist BLU-5937 has obtained positive results

P2X3 receptors are ion channels expressed on sensory nerves, and they play an important role in the sensitization of various stimuli in the nervous system

The results of the test showed that on the 28th day, the placebo-adjusted 24-hour cough frequency of the 50 mg and 200 mg BLU-5937 groups was reduced by 34%, which was clinically significant and statistically significant (p≤0.

▲Efficacy results of BLU-5937 (picture source: BELLUS Health official website)

In addition, the safety and tolerability data of BLU-5937 are consistent with previous trials, and have a lower impact on patients' taste.

Reference materials:

[1] BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.